FUS and amyotrophic lateral sclerosis: Importantly, fibril-induced FUS pathology spread from the site of injection to more distal brain regions in a time-dependent fashion, being more pronounced in the presence of ALS-associated FUS mutations, and ultimately exacerbated age-dependent cognitive and behavioral deficits from mutant human FUS expression.